Michelle Davis, Head of External Relations at Malaria Consortium, shares with us what we need to know about learning from COVID-19 and the continuing fight against malaria.
Arthur Lupia with Deborah H. Olster from the Directorate for Social, Behavioral and Economic Sciences at the U.S. National Science Foundation, explain the power of international collaboration when it comes to social and behavioural science responding to COVID-19.
The Canadian Institutes of Health Research, part of the Government of Canada, has an Institute of Infection and Immunity. Here, we gain a flavour of what they do.
Open Access Government caught up with Dr Mary Stephen, Public Health Expert at the World Health Organization African Region, provides an update on the COVID-19 outbreak in Africa.
Chairs of the Parliament’s Coalition for Mental Health and Wellbeing demand immediate action to address the growing mental health crisis and the creation of a long-term Mental Health Strategy.
Here, we interview Alex Wilson, Co-founder of specialist reagent company PCR Biosystems, discussing how their expertise in enzyme development and large-scale production has been successfully applied to COVID-19 testing solutions around the world.
The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the Pfizer/BioNTech COVID-19 vaccine is safe to use in 12-15-year-olds.
Graham Mimms, Hygiene Aviation Expert and co-founder of Safe Surface Sensor, explains why the only way to stop a future health crisis is to ensure we have strict hygiene policies in place.
Graham Brookes, Agricultural Economist with PG Economics, UK, charts how the development and deployment of COVID-19 vaccines, derived using techniques of genetic modification, highlight ideological inconsistency and hypocrisy.
Kate Edwards, Director at Intelligent Infection Control Services Limited, LumiBio, underlines the importance of creating safe environments for the patient, clinician & support worker in the NHS.
According to a new study, led by the University of Pennsylvania, specially trained detection dogs can sniff out positive COVID-19 samples with 96% accuracy.
